Search Login Register

Stomach Neoplasms (Stomach Cancer) Summary

Description: Tumors or cancer of the STOMACH.

Also Known As: Stomach Cancer; Gastric Cancer; Cancer, Gastric; Cancer of the Stomach; Neoplasms, Gastric Show All >>

Networked: 23996 relevant articles (1653 outcomes, 5160 trials/studies) for this Disease

Key Drugs and Agents for Stomach Neoplasms

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Fluorouracil (Carac) : 168 outcomes 405 studies in 1331 results : FDA 33 Generic
  2. Cisplatin (Platino) : 147 outcomes 391 studies in 1091 results : FDA 6 Generic
  3. Paclitaxel (Taxol) : 118 outcomes 154 studies in 468 results : FDA 13 Generic
  4. docetaxel (Taxotere) : 87 outcomes 169 studies in 434 results : FDA 3
  5. titanium silicide (TS-1) : 72 outcomes 36 studies in 243 results : IBA
  6. trastuzumab (Herceptin) : 62 outcomes 77 studies in 272 results : FDA 2
  7. oxaliplatin (Eloxatin) : 56 outcomes 140 studies in 293 results : FDA 14 Generic
  8. capecitabine (Xeloda) : 52 outcomes 116 studies in 226 results : FDA 1
  9. irinotecan (Camptosar) : 50 outcomes 114 studies in 323 results : FDA 19 Generic
  10. Leucovorin (Folinic Acid) : 47 outcomes 153 studies in 300 results : FDA 6
Show All >>

Diseases Related to Stomach Neoplasms

  1. Neoplasm Metastasis (Metastasis)
  2. Neoplasms (Cancer)
  3. Ascites
  4. Carcinoma (Carcinomatosis)
  5. Stomach Neoplasms (Stomach Cancer)
Show All >>

Key Therapies for Stomach Neoplasms

Efficacy Chart >>
  1. Drug Therapy (Chemotherapy) : 445 outcomes 700 studies in 3278 results
  2. Gastrectomy : 210 outcomes 624 studies in 4083 results
  3. Combination Drug Therapy (Combination Chemotherapy) : 94 outcomes 106 studies in 463 results
  4. Lymph Node Excision (Lymph Node Dissection) : 74 outcomes 193 studies in 1245 results
  5. Adjuvant Chemotherapy : 72 outcomes 179 studies in 543 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.